Introduction:
The pharmaceutical industry in India has been experiencing significant growth in recent years, with a focus on vaccine production and supply. The country has emerged as a key player in the global vaccine market, with several top companies leading the way in raw material supply. In 2026, the top 10 vaccine raw material suppliers in India are making a significant impact on the industry, with their production volumes and market shares steadily increasing.
Top 10 Vaccine Raw Material Suppliers in India 2026:
1. Serum Institute of India
– Production volume: 1.5 billion doses per year
– Serum Institute of India is the world’s largest vaccine manufacturer by number of doses produced. They have been instrumental in supplying vaccines to various countries around the world, including low-income nations through initiatives like COVAX.
2. Bharat Biotech
– Market share: 25% in the Indian vaccine market
– Bharat Biotech is a leading biotechnology company in India, known for developing innovative vaccines for various diseases. Their extensive research and development efforts have positioned them as a key player in the vaccine raw material supply chain.
3. Panacea Biotec
– Exports: 30% of their vaccine raw materials
– Panacea Biotec is a renowned pharmaceutical company in India with a strong presence in the vaccine market. Their focus on quality and innovation has made them a preferred supplier for many global vaccine manufacturers.
4. Biocon
– Market share: 15% in the Indian vaccine market
– Biocon is a prominent biopharmaceutical company that has diversified into vaccine production in recent years. Their commitment to research and development has enabled them to deliver high-quality raw materials for vaccines.
5. Hester Biosciences
– Production volume: 500 million doses per year
– Hester Biosciences is a leading supplier of animal vaccines in India, with a growing presence in the human vaccine market. Their extensive manufacturing capabilities have positioned them as a reliable source for vaccine raw materials.
6. Indian Immunologicals
– Exports: 20% of their vaccine raw materials
– Indian Immunologicals is a key player in the vaccine industry, with a focus on producing essential raw materials for a wide range of vaccines. Their commitment to quality control and regulatory compliance has made them a trusted partner for global vaccine manufacturers.
7. Shantha Biotechnics
– Market share: 10% in the Indian vaccine market
– Shantha Biotechnics is a subsidiary of Sanofi Pasteur, a global pharmaceutical company. Their expertise in vaccine production and technology transfer has enabled them to supply high-quality raw materials for various vaccines.
8. Zydus Cadila
– Production volume: 300 million doses per year
– Zydus Cadila is a leading pharmaceutical company in India, with a strong focus on vaccine development and production. Their state-of-the-art manufacturing facilities ensure the supply of top-quality raw materials for vaccines.
9. Indian Immunologicals Limited
– Exports: 15% of their vaccine raw materials
– Indian Immunologicals Limited is a subsidiary of the National Dairy Development Board of India. They are known for their expertise in vaccine production and have been supplying raw materials to various countries around the world.
10. Biological E Limited
– Market share: 8% in the Indian vaccine market
– Biological E Limited is a Hyderabad-based biopharmaceutical company with a strong presence in the vaccine market. Their focus on research and development has enabled them to produce high-quality raw materials for vaccines.
Insights:
The Indian vaccine raw material supply market is witnessing significant growth, driven by the increasing demand for vaccines globally. The COVID-19 pandemic has further highlighted the importance of vaccine production and supply, leading to a surge in investments in the sector. With the Indian government’s push for self-reliance in vaccine manufacturing, the top 10 suppliers are expected to play a crucial role in meeting the growing demand for vaccines. In the coming years, collaborations between Indian companies and global vaccine manufacturers are likely to increase, further boosting the country’s position as a key player in the vaccine industry.
Related Analysis: View Previous Industry Report
